Skip to main content
. Author manuscript; available in PMC: 2013 Feb 1.
Published in final edited form as: Aust N Z J Psychiatry. 2012 Feb;46(2):141–152. doi: 10.1177/0004867411433212

Table 1.

Demographic and Psychiatric Characteristics of the Study Participants

Variable MA− (n = 110) MA+ (n = 114) p
Demographic Characteristics
 Age (years) 37.6 (12.4) 37.3 (9.3) 0.83
 Education (years) 12.4 (1.9) 11.9 (2.3) 0.11
 Sex (% men) 63.6 70.2 0.30
 Ethnicity (% Caucasian) 69.1 76.3 0.26
 Estimated verbal IQ a 99.9 (10.5) 97.5 (9.5) 0.07
Hepatitis C Infection (% seropositive) 21 (20.4%) 36 (31.6%) 0.06
Psychiatric Characteristics b
 Major Depressive Disorder (%)
  Current 7.3 6.1 0.79
  Lifetime 31.8 30.7 0.89
 Bipolar Disorder(%)
  Current 0.0 4.4 0.06
  Lifetime 0.9 6.1 0.07
 ADHD
  Current 0.9 10.0 0.005
  Lifetime 2.8 15.5 0.002
 ASPD 0.0 23.7 <0.001
 Methamphetamine Use Characteristics c
  Last use (days since last use) -- 91 (45, 167) --
  Cumulative duration of use (days of use) -- 3960 (2130, 5826) --
  Cumulative quantity of use d -- 2908.0 (1180.0, 5833.0) --
  Duration of use in last 30 days (days) -- 3.0 (2.0, 8.0) --
  Quantity used in last 30 days d -- 3.0 (0.3, 6.0) --
  Quantity used in last 12 months d -- 136.8 (18.0, 540.0) --
 Other Substance Use Disorders e
  Canabis dependence 8.2 19.3 0.02
  Opioid dependence 5.5 4.4 0.77
  Cocaine dependence 6.4 18.4 0.02
  Alcohol dependence 15.5 41.2 <0.001
  Other substance dependence f 1.8 1.8 0.97
 POMS Total Mood Disturbance g 51.9 (35.6) 64.4 (39.8) 0.014

Note.

a

Based on the WRAT-3 Reading Standard Score;

b

p-values based on Fisher’s Exact Test;

c

data presented as medians and IQRs;

d

quantity of MA used presented in grams;

e

lifetime diagnoses;

f

other substance dependence = hallucinogens and sedatives; and

g

POMS = Profile of Mood States.